Zhi Jian Chen
Directeur/Membre du Conseil chez Shanghai Haihe Biopharma Co., Ltd.
Profil
Zhi Jian Chen is currently a Director at Huatai Futures Co., Ltd.
and a Director at Shanghai Haihe Biopharma Co., Ltd.
He was previously a Director at Deluxe Family Co., Ltd.
from 2008 to 2012 and a Member-Supervisory Board at Shanghai Nanjiang Group Co. Ltd.
in 2012.
Postes actifs de Zhi Jian Chen
| Sociétés | Poste | Début |
|---|---|---|
Shanghai Haihe Biopharma Co., Ltd.
 Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Directeur/Membre du Conseil | 01/01/2018 |
Huatai Futures Co., Ltd.
 Huatai Futures Co., Ltd. Investment ManagersFinance Part of Huatai Securities Co., Ltd., Huatai Futures Co., Ltd. provides investment brokerage and asset management services. The company is based in Guangzhou, China. The Chinese company was founded in 1994. The CEO is Chang Tao Zhao. | Directeur/Membre du Conseil | 28/12/2010 |
Anciens postes connus de Zhi Jian Chen
| Sociétés | Poste | Fin |
|---|---|---|
| DELUXE FAMILY CO., LTD. | Directeur/Membre du Conseil | 31/05/2012 |
| Shanghai Nanjiang Group Co. Ltd. /Old/ | Directeur/Membre du Conseil | 06/01/2012 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DELUXE FAMILY CO., LTD. | Finance |
| Entreprise privées | 3 |
|---|---|
| Shanghai Nanjiang Group Co. Ltd. /Old/ | Finance |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |
Huatai Futures Co., Ltd.
Huatai Futures Co., Ltd. Investment ManagersFinance Part of Huatai Securities Co., Ltd., Huatai Futures Co., Ltd. provides investment brokerage and asset management services. The company is based in Guangzhou, China. The Chinese company was founded in 1994. The CEO is Chang Tao Zhao. | Finance |
